Correlation Between CVR Partners and Medicus Pharma

Can any of the company-specific risk be diversified away by investing in both CVR Partners and Medicus Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CVR Partners and Medicus Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CVR Partners LP and Medicus Pharma Ltd, you can compare the effects of market volatilities on CVR Partners and Medicus Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CVR Partners with a short position of Medicus Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CVR Partners and Medicus Pharma.

Diversification Opportunities for CVR Partners and Medicus Pharma

0.03

Correlation Coefficient

CVR Partners  Medicus Pharma

Significant diversification

The 3 months correlation between CVR and Medicus is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding CVR Partners LP and Medicus Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicus Pharma and CVR Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CVR Partners LP are associated (or correlated) with Medicus Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicus Pharma has no effect on the direction of CVR Partners i.e., CVR Partners and Medicus Pharma go up and down completely randomly.

Pair Corralation between CVR Partners and Medicus Pharma

Considering the 90-day investment horizon CVR Partners is expected to generate 6.9 times less return on investment than Medicus Pharma. But when comparing it to its historical volatility, CVR Partners LP is 5.46 times less risky than Medicus Pharma. It trades about 0.07 of its potential returns per unit of risk. Medicus Pharma Ltd is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  245.00  in Medicus Pharma Ltd on December 19, 2024 and sell it today you would earn a total of  63.00  from holding Medicus Pharma Ltd or generate 25.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CVR Partners LP  vs.  Medicus Pharma Ltd

CVR Partners LP

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CVR Partners LP are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, CVR Partners may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Medicus Pharma

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Medicus Pharma Ltd are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating fundamental indicators, Medicus Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CVR Partners and Medicus Pharma

The main advantage of trading using opposite CVR Partners and Medicus Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CVR Partners position performs unexpectedly, Medicus Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicus Pharma will offset losses from the drop in Medicus Pharma's long position.

The idea behind CVR Partners LP and Medicus Pharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.